AbbVie Inc. (ABBV)

83.33
1.90 2.30
NYSE : Health Technology
Prev Close 85.27
Open 85.43
Day Low/High 82.76 / 85.48
52 Wk Low/High 62.66 / 91.99
Volume 6.92M
Avg Volume 7.29M
Exchange NYSE
Shares Outstanding 1.48B
Market Cap 128.97B
EPS 3.70
P/E Ratio 38.25
Div & Yield 4.72 (4.86%)

Abbvie downgraded at BofA/Merrill

Why I'm Sticking With Biotech

Why I'm Sticking With Biotech

They offer a nice shelter for the headwinds now hitting equities.

Gilead Is Set to Surge

Its hepatitis C drug will dominate the market.

Gilead Is a Buying Opportunity

Gilead Is a Buying Opportunity

Its hepatitis C drug is better; the stock trades at a discount.

Heed the Rotation

Stocks that do well when the economy rises are shining.

In Defense of Gilead Sciences

In Defense of Gilead Sciences

It has a great long-term future.

How Competition Hurts a Stock

It might be good for consumers, but not for the stock.

Three Large-Cap Growth Stocks

Three Large-Cap Growth Stocks

I would pick up some large caps on any significant dips.

Abbvie downgraded at Morgan Stanley

Buy Gilead Sciences

Buy Gilead Sciences

Its prospects exploded with a breakthrough drug.

AbbVie downgraded at BMO

Avoid the Crowd

There is virtually no room for error in a crowded trade.

Boxes: Checked!

Boxes: Checked!

We now have an investable bottom on our hands.

Run for Shelter in Community Banks

It's unlikely that they will be hit by Europe or the Ebola scare. 

We Aren't Done Yet

There will likely be more selling until the elusive bottom is reached.

This Morning's Market Setup

 Where it began. The rundown: U.S. futures are bouncing all over (now at their lows). S&P 500 futures are -16 and Nasdaq futures are -31 handles. Europe is broadly lower .  Japan is +0.92% following a quiet night of news. The yen has weakened a bit ...

Five Things to Know Now: Apple, Facebook and Women

The two tech giants help women freeze their eggs.

U.S. Stories Offset European Weakness

We are buying the weakness, albeit slowly.

AbbVie upgraded at UBS

European Markets Are Spooked by Ukraine and Gaza, but AbbVie Gets Shire Deal

European Markets Are Spooked by Ukraine and Gaza, but AbbVie Gets Shire Deal

European markets followed New York and Asia down this morning as investors were spooked by the shooting down of a Malaysian Airlines plane over Eastern Ukraine.

Futures Mixed in Reaction to Int'l Headlines; AbbVie, Shire Deal

Futures Mixed in Reaction to Int'l Headlines; AbbVie, Shire Deal

The futures markets are mixed this morning as news of the Malaysian Airlines plane shot down in the Ukraine and tensions in Gaza dominate investors minds.

This Morning's Market Setup

Where it began. The rundown: U.S. futures are higher this morning (S&P up 6 handles, Nasdaq up 18 handles). European stocks are climbing, too (by about 0.8%). Nikkei is up 0.88%. Within the Nikkei, all major sub-groups finished in the green. Telecom...

Abbvie upgraded at Morgan Stanley

Spend Is a Four-Letter Word

Spend Is a Four-Letter Word

The market wants companies that are taking share with minimal spending.

Gilead Sciences: A Top Pick Update

Gilead Sciences: A Top Pick Update

Investors may be worried about Sovaldi's price.

Miracle Drug May Be Ailing Gilead

Miracle Drug May Be Ailing Gilead

Its potent hepatitis C treatment is not a boon for shareholders.

Dividend D-Day Coming

Dividend D-Day Coming

The goal is always simply to get out where we got in.

AbbVie price target lowered at Jefferies